Systemic Review : The Study on Ovarian hyperstimulation syndrome(OHSS)

Pub Med에서 검색된 난소 과자극 증후군에 대한 최신 연구 고찰

  • Jung, Minyung (Dept. of Gynecology, College of Oriental Medicine, Sangji Univ.) ;
  • Sohn, Youngjoo (Dept. of Gynecology, College of Oriental Medicine, Sangji Univ.)
  • 정민영 (상지대학교 부속한방병원 부인과) ;
  • 손영주 (상지대학교 부속한방병원 부인과)
  • Received : 2005.01.26
  • Accepted : 2005.02.03
  • Published : 2005.02.28

Abstract

Objective : To know about ovarian hyperstimulation syndrome pathophysiology, risk factors and clinical features and to research the trend of the study related to OHSS. Methods : We referred a PubMed site by using searching word of "ovarian hyperstimulation syndrome"(Limits: 1 Year, only items with abstracts, Human). Results : 28 journals with 49 papers were searched. Conclusion 1. The study of OHSS subjects on pathophysiology, prevention and medical treatment. 2. As OHSS is an exaggerated response to ovulation induction therapy, it's emphasized that aspect of prevention OHSS. 3. Preventing OHSS are the following. The first is to give a GnRH agonist or antagonist in substitute for hCG. The second is to screen out prevalence of thrombophilia. The third is to monitor $E_2$ levels. The forth is to aspirate of Mediculous follicle. The fifth is cryopreservation of all embryos. The sixth is that administration of albumin for treatment of OHSS. But, it's not useful to administration of albumin for prevention of OHSS. 4. There's no therapy of OHSS. But, there's only symptomatic treatment of OHSS.

Keywords

References

  1. Fertility and sterility v.80 no.5 Ovarian hyperstimulation syndrome. The Practice Committee of the American Society for Reproductive Medicine.
  2. Br J obstet Gynnaecol. v.102 no.10 Digonosis, prevention and management of ovarian hyperstimulation syndrome. Brisden PR(외 4인)
  3. Fertil Steril v.30 Ovarian hyperstimulation syndrome : A current survey. Schenker JG;Weinstein D
  4. Pathology v.27 A fetal case of Ovarian hyperstimulation syndrome with cerebral infaction. Cluroe AD;Synek BJ
  5. Am J Obstet Gynecol v.159 Risk factors and Prognostic variables in the Ovarian hyperstimulation syndrome. Navot D(외 4인)
  6. 대한 산부회지 v.37 no.10 배란 유도시 발생한 중증 난소 과자극 증후군에 대한 임상적 고찰. 김홍필(외 7인)
  7. Hum Reprod. v.19 no.3 The effect of 'coasting' on follicular fluid concentrations of Vascular endothalial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Tozer AJ(외 5인)
  8. Hum Reprod. v.19 no.3 New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spotaneous and iatrogenic syndrome? Delbaere A;Smits G;Olatunbosun O;Pierson R;Vassart G;Costagliola S
  9. J Clin Endocrinol Metab. v.89 no.4 A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. Montanelli L;Delbaere A;Di Carlo C;Nappi C;Smits G;Vassart G;Costagliola S
  10. Drugs. v.64 no.3 Contemporary pharmacological manipulation in assisted reproduction. Huirne JA, Lambalk CB, van Loenen AC, Schats R;Hompes PG;Fauser BC;Mackol NS
  11. Fertility and sterility v.81 no.1 Luteolysis induced by gonadotropin-releasing hormon agonist is the key to prevention of Ovarian hyperstimulation syndrome. Shahar Kol
  12. Fertility and sterility v.81 no.4 Prevalence of Thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Francisco Fabregues;Dolors Tassies;Juan C. Reverter;Franciscoarmona;Antonio Ordinas;Juan Balasch
  13. Fertility and Sterility v.81 no.2 Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study. Arianna D'Angelo M.D.(외 4인)
  14. Fertil Steril v.82 no.2 Interlukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Barak V;Elchalal U;Edelstein M;Kalickman I;Lewin A;Abramov Y
  15. Zhonghua Fu Chan Ke Za Zhi v.39 no.8 Outcome of follicular aspiration of selection phase in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. Zhu WJ. Li XM;CHen XM;Zhang L
  16. Fertility and sterility v.81 no.2 Cumulative first live birth after elective cryopreservation of all embryos due to ovarian hyperresponsiveness. Ian S. Tummon;Stephen A. Contag;Alan R. Thornhill;Donna R. Session;Daniel A. Dumesic;Mark A. Damario
  17. Hum Reprod v.18 no.11 Intravenenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Bellver J(외 7인)
  18. Hum Reprod v.18 no.11 Thromboembolism after ovarian stimulation : successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer : case report. OU YC;Kao YL;Lai SL;K ung FT;Huang FJ;Chang SY;ChangChien CC
  19. J Chin Med Assoc v.67 no.4 Continous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome. Chan CC;YinCS;Lan SC;Chen IC;Wu GJ
  20. Fertil Steril v.81 no.4 Unilateral pleural effusion as the main presentation of "early onset" servere ovarian hyperstimulation syndrome. Andrew Murray;M.B. Ch. B.;Luk Rombauts
  21. 부인과학 대한 산부인과학회
  22. WHO Technical Report Serise v.514
  23. Eur J Obstet Gynecol Reprd Bio v.85 Clinical aspects of ovarian hyperstimulation syndrome. Schenker JG
  24. Fertil Steril v.74 Role of vascular endothelial growth factor in ovarian physiology and pathology. Geva E;Jaffe RB
  25. Gynecol Surv v.50 Angiogenesis in the human female reproductive tract. Gordon JD(외 4인)
  26. J Clin Endocrinol Metab v.71 Use of gonadotropin releasing hormone agonist to trigger follicular maturation for in vitro fertilation. Gonen Y;Balakier H;Powell W;Casper RF
  27. Reproductive Medicine and Surgery. ovarian hyperstimulation syndrome. Schenker JG;Wallach EE(ed);Zacur HA(ed)
  28. Fertil Steril v.71 Withholding gonadotropins9coasting) tominimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fluker ML;Hooper W;Yuzpe AA
  29. Hum Reprod v.14 Prospective randomized study of human chorionic gonadotropin versus intramuscular progesterone for invitro fertilization Araujo E(외 4인)
  30. Fertil Steril v.53 The management of predicted OHSS involving gonadotropin-releasing hormone analogte with elective cryopreservaton of all preembryos. Amso NN;Abuga KK;Morris N;Shaw RW
  31. Hum Reprod. v.5 Elective cryopreservationof allpronucleate embryos in woman at risk of ovarian hyperstimulation syndrome: efficiency and safety. Ferraretti AP;Gianoreli L;Magli C;Selman HA;Feliclani E
  32. J Assist Reprod Genet v.13 Early timed follicular aspiration preventsevere ovarian hyperstimulation syndrome. Tomazevic T;Moden-Vrtovec H.
  33. Fertil steril v.51 Servere ovarian hyperstimulation syndrome: a reelevated therapeutic approach. Borenstein R;Elhalah U;Lunenfeld B;Schwartz Zs
  34. Fertil Steril v.40 Plasma estradiol is superior to ultrasound and urinary estradiol glucuronide as apredictor of ovarian hyperstimulation during induction of ovulation with menotrpins. Haning Rv(외 5인)
  35. 대한 산부회지 v.47 no.6 내경 정맥 혈전증을 동반한 중증 난소과자극 증후군 1예
  36. 대한 결핵 및 호흡기 질환 v.44 no.3 다량의 흉수를 동반한 난소 과자극 증후군 1례 박형관(외 6인)
  37. 부인과 내분비학 구병삼
  38. 대한불임학회지 v.12 난소에서의 난포기 발육과 관련되는 성스테로이드 대사의 역할. 서병희;이재현
  39. Am J Obstet Gynecol v.96 Human menopauseal gonadotropins for anovaulation and sterlity. Rabau E.;Serr D.M.;David A.;Mashias S.;Lunenfeid B.
  40. Fertil Steril v.50 Selective oocyte retrieval : a new approach to ovarian hyperstimulation. Belaisch-Allart J;Testart J;Belaish J(et al.)
  41. Br Med J v.300 Human albumin solutions. Mcclelland DB.
  42. Fertil Steril v.62 Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program : a prostective randomized. placebo-controlled study. Shoham Z;Borenstein R;Weissman A(et al.)
  43. Hum reprod v.8 The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Asch RH;Ivery G. Goldman M(et al.)
  44. 대한산부회지 v.39 no.2 중증 난소 과자극 증후군의 고 위험군에서 예방적 Albumin 정맥주사요법의 효과. 조윤경;김정훈;목정은